Skip to main content
2024 Canadian Cardiovascular Congress Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Handout
Handout
Networking
Networking
On-Demand
On-Demand
Early Career Involvement
Early Career Involvement
Back

Jacqueline Saw, MD, FRCPC

Interventional Cardiologist
CAIC
University of British Columbia

Dr. Jacqueline Saw is an Interventional Cardiologist at Vancouver General Hospital (VGH) with joint appointment at St Paul’s Hospital. She is a Clinical Professor of Medicine at the University of British Columbia, and Program Director of the Interventional Cardiology Fellowship Program at VGH. She also served as the Head of VGH Cardiology Clinical Trials Research. She is an active clinician, researcher and educator.

She was awarded Canada Scholar and the Dean’s Entrance Scholarship for Natural Sciences at Simon Fraser University for her undergraduate degree. She obtained her medical doctorate at the University of Ottawa, graduating summa cum laude. She completed her Internal Medicine and Cardiology residencies at the University of British Columbia, and served as chief cardiology fellow. She then completed her Interventional Cardiology fellowship training at Cleveland Clinic Foundation, which encompassed carotid, peripheral and structural training. She has been an active staff with the Division of Cardiology at VGH and St Paul’s Hospital since 2004. She is also a physician proctor for left atrial appendage (LAA) closure with the WATCHMAN and Amplatzer Cardiac Plug/Amulet devices.

Dr. Saw is a pioneer and leader in research and management of spontaneous coronary artery dissection (SCAD) (http://scad.ubc.ca), and is the principal investigator of the Canadian Institutes of Health Research (CIHR) funded multi-center prospective Canadian SCAD Study, and the Heart and Stroke Foundation funded Canadian SCAD Genetic Study. Her research interests include LAA closure, non-atherosclerotic coronary artery disease (including coronary fibromuscular dysplasia), antiplatelet therapy, percutaneous coronary intervention, carotid artery stenting, peripheral arterial disease and intervention. She is also the principal investigator of PRYME, NACAD, SAFER-SCAD, Canadian WATCHMAN Registry, TAP-CABG, and ELAPSE studies. She has authored over 200 peer-reviewed publications, including scientific research manuscripts, review papers, book chapters and abstracts. She is also the editor of three textbooks on LAA closure and carotid artery stenting.

Disclosure information not submitted.

Presentation(s):